formulated nucleic acid pharmaceutical preparations for the treatment of autoimmune diseases, acquired diseases in the nature of coronary artery disease, lung cancer, and melanoma, and genetic diseases in the nature of cystic fibrosis, asthma, breast cancer, and ovarian cancer